PCH
DYN icon

Polar Capital Holdings’s Dyne Therapeutics DYN Stock Holding History

Polar Capital Holdings’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Sell
1,286,811
-72,358
-5% -$1.35M 0.07% 153
2026
Q1 		$24.6M Buy
1,359,169
+90,038
+7% +$1.55M 0.09% 131
2025
Q4 		$24.8M Buy
1,269,131
+739,743
+140% +$14M 0.1% 142
2025
Q3 		$6.7M Buy
+529,388
New +$6.04M 0.03% 213
2023
Q3 		– Sell
-500,000
Closed -$5.63M – 287
2023
Q2 		$5.63M Buy
+500,000
New +$5.9M 0.03% 225

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Polar Capital Holdings's DYN Position: Q2 2026 in Review

Polar Capital Holdings reduced its Dyne Therapeutics (DYN) stake by 5.3% in Q2 2026, selling an estimated $1.35M and leaving 1,286,811 shares worth $28.6M. The position accounts for 0.07% of the portfolio, ranked #153.

Polar Capital Holdings first reported a position in DYN in Q2 2023 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Polar Capital Holdings held 1,286,811 shares of Dyne Therapeutics worth $28.6M as of Q2 2026.
  • Polar Capital Holdings sold 72,358 Dyne Therapeutics shares in Q2 2026, an estimated $1.35M.
  • Dyne Therapeutics made up 0.07% of Polar Capital Holdings's portfolio in Q2 2026, its #153 holding.
  • Polar Capital Holdings first reported a position in Dyne Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.